rodintherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Alkermes – A Global Biopharmaceutical |
| Description | Great ScienceDeep CompassionReal Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and |
| Keywords | Lybalvi, Alks 1140, Neuroscience, LYBALVI™ (olanzapine and samidorphan), Schizophrenia, Bipolar I Disorder, Neurology, Orphan, Oncology, Nemvaleukin alfa |
Server Information
| WebSite | |
| Host IP | 174.143.31.7 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
rodintherapeutics.com Valuation
|
US$910
Last updated: 2023-05-15 23:38:24
rodintherapeutics.com has Semrush global rank of 0. rodintherapeutics.com has an estimated worth of US$ 910, based on its estimated Ads revenue. rodintherapeutics.com receives approximately 105 unique visitors each day. Its web server is located in United States, with IP address 174.143.31.7. According to SiteAdvisor, rodintherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$910 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$25 |
| Yearly Ads Revenue | US$302 |
| Daily Unique Visitors | 7 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| rodintherapeutics.com. | A | 600 | IP: 174.143.31.7 |
| rodintherapeutics.com. | NS | 86400 | NS Record: ns-372.awsdns-46.com. |
| rodintherapeutics.com. | NS | 86400 | NS Record: ns-631.awsdns-14.net. |
| rodintherapeutics.com. | NS | 86400 | NS Record: ns-1517.awsdns-61.org. |
| rodintherapeutics.com. | NS | 86400 | NS Record: ns-1967.awsdns-53.co.uk. |
| rodintherapeutics.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
| rodintherapeutics.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
| rodintherapeutics.com. | TXT | 3600 | TXT Record: t3hhtxz49jrl6tqjrd06wcsxl2n22czb |
| rodintherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:us._netblocks.mimecast.com -all |
HtmlToTextCheckTime:2023-05-15 23:38:24
| About Us Discover Alkermes Our Values Leadership Diversity, Inclusion & Belonging Collaborations Locations Medicines & Focus Our Focus Disease Areas Innovative Medicines Third-Party Medicines Research & Development Pipeline Scientific Platforms Technologies & Capabilities Research & Medical Grants Clinical Trials Early Access Responsibility Corporate Responsibility Patient Engagement & Advocacy Alkermes Inspiration Grants ® Corporate Giving Corporate Responsibility Reports Public Policy Investors Press Releases Investor Events / Presentations SEC Filings Annual Reports Corporate Governance Stock Information Investor Resources Email Alerts News & Events Press Releases Our Stories Media Resources Statements Contact Us Careers Working Here Our Culture Benefits Join Our Team Great Science Deep Compassion Real Impact Working together to address addiction, serious mental illness and cancer. Discover Alkermes Featured News May 09, 2023 Alkermes Announces Two Abstracts Accepted for |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 146 Content-Type: text/html; charset=UTF-8 Location: http://www.alkermes.com Server: Microsoft-IIS/8.5 X-Powered-By: ASP.NET Date: Sat, 15 Jan 2022 11:23:35 GMT HTTP/1.1 303 See Other Content-Length: 148 Content-Type: text/html; charset=UTF-8 Location: https://www.alkermes.com/ Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET Content-Security-Policy: frame-ancestors https://admin.alkermes.com https://www.alkermes.com X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Date: Sat, 15 Jan 2022 11:23:36 GMT HTTP/2 200 cache-control: no-cache pragma: no-cache content-length: 29277 content-type: text/html; charset=utf-8 expires: -1 server: Microsoft-IIS/10.0 x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET content-security-policy: frame-ancestors https://admin.alkermes.com https://www.alkermes.com x-xss-protection: 1; mode=block x-content-type-options: nosniff date: Sat, 15 Jan 2022 11:23:36 GMT |
rodintherapeutics.com Whois Information
Domain Name: RODINTHERAPEUTICS.COM Registry Domain ID: 1801247069_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-05-17T11:07:29Z Creation Date: 2013-05-14T16:28:43Z Registry Expiry Date: 2022-05-14T16:28:43Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1517.AWSDNS-61.ORG Name Server: NS-1967.AWSDNS-53.CO.UK Name Server: NS-372.AWSDNS-46.COM Name Server: NS-631.AWSDNS-14.NET DNSSEC: unsigned >>> Last update of whois database: 2022-01-15T07:24:18Z <<< |